P1‐046: BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL‐TO‐MILD) ALZHEIMER'S DISEASE. (1st July 2019)
- Record Type:
- Journal Article
- Title:
- P1‐046: BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL‐TO‐MILD) ALZHEIMER'S DISEASE. (1st July 2019)
- Main Title:
- P1‐046: BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL‐TO‐MILD) ALZHEIMER'S DISEASE
- Authors:
- Sink, Kaycee
Warren, Francis
Smith, Jillian
Schneider, Andres
Fuji, Reina N.
Quartino, Angelica
Mackey, Howard
Rabbia, Michael
Yule, Susan
Fontoura, Paulo
Doody, Rachelle
Ostrowitzki, Susanne - Abstract:
- Is Part Of:
- Alzheimer's & dementia. Volume 15:Supplement 7(2019)Part 4
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 15:Supplement 7(2019)Part 4
- Issue Display:
- Volume 15, Issue 7, Part 4 (2019)
- Year:
- 2019
- Volume:
- 15
- Issue:
- 7
- Part:
- 4
- Issue Sort Value:
- 2019-0015-0007-0004
- Page Start:
- P250
- Page End:
- P250
- Publication Date:
- 2019-07-01
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jalz.2019.06.071 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13304.xml